<?xml version="1.0" encoding="UTF-8"?>
<p id="Par44" class="p">One study on macrocyclic anthelmintics confirmed the clinical efficacy of the semi-synthetic oxime of a milbemycin (Fig.Â 
 <xref rid="Fig8" ref-type="fig" class="xref">8</xref>) in treating dogs infected with 
 <italic class="italic">Toxocara canis, Toxascaris leonina</italic>, 
 <italic class="italic">Trichuris vulpis</italic> or 
 <italic class="italic">Ancylostoma caninum</italic> [
 <xref ref-type="bibr" rid="CR105" class="xref">105</xref>]. Milbemycin oxime and another semisynthetic milbemycin, moxidectin, are part of numerous pesticide combinations used in animals. The latter has also recently received FDA approval for use in humans in the treatment of river blindness [
 <xref ref-type="bibr" rid="CR106" class="xref">106</xref>].
</p>
